Global Yellow Fever Vaccine Market Report 2025

Yellow Fever Vaccine Global Market Report 2025 – By Product (Powder, Liquid), By Treatment Type (Pain Management Drugs, Oral Rehydration), By Application (Routine Immunization, Travelers, Other Applications), By End-User (Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Yellow Fever Vaccine Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Yellow Fever Vaccine Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Yellow Fever Vaccine Market Definition

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas.

The main products of the yellow fever vaccine are powder and liquid. Yellow fever vaccine powder is a lyophilized (freeze-dried) form of the yellow fever vaccine, which requires reconstitution with a specific diluent before administration to provide immunity against the yellow fever virus. This involves various treatment types, such as pain management drugs and oral rehydration. This vaccine finds application in routine immunization, travelers, and others and is used by several end users, mainly hospitals, diagnostic centers, point-of-care centers, and others.

Yellow Fever Vaccine Market Segmentation

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Yellow Fever Vaccine Market Size and growth rate 2025 to 2029: Graph

Yellow Fever Vaccine Market Size 2025 And Growth Rate

The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.

Yellow Fever Vaccine Market Growth Forecast

The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.

Yellow Fever Vaccine Market Driver: Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel

Increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for purposes such as tourism, business, or personal reasons. International travel is rising due to increased global connectivity, economic growth, and the relaxation of travel restrictions post-pandemic. The yellow fever vaccine is required or recommended for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health regulations. For instance, in January 2024, according to the World Tourism Organization, a Spain-based agency, in 2023, there were 1.286 billion international tourists (overnight visitors) globally, while in 2022, there were 960 million international tourists (overnight visitors). This shows an increase of 326 million international tourists from 2022 to 2023. Therefore, increasing international travel is driving the growth of the yellow fever vaccine market.

Global Yellow Fever Vaccine Market Major Players

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Global Yellow Fever Vaccine Market Trend: Innovative T-Cell Adaptive Booster Vaccines Enhancing Global Yellow Fever Immunity

Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. A T-cell adaptive booster vaccine is a type of vaccine designed to enhance the immune system's memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.

Yellow Fever Vaccine Market Merger And Acquisition: Emergex Enhances Vaccine Development Capabilities With Zosano Pharma Inc. Acquisition

In October 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, acquired the assets of Zosano Pharma Corporation for an undisclosed amount. Acquiring Zosano Pharma Inc. would benefit Emergex Vaccines Holding Limited by expanding its technological capabilities in transdermal delivery systems, enhancing its vaccine delivery methods, and accelerating the development and commercialization of innovative vaccines, including those targeting yellow fever. Zosano Pharma Inc. is a US-based pharmaceutical company that provides therapeutics and other bioactive molecules to patients using its transdermal microneedle system.

Regional Outlook For The Global Yellow Fever Vaccine Market

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yellow fever vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Yellow Fever Vaccine Market?

The yellow fever vaccine market consists of sales of vaccine syringes, needles, and vaccine storage equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Yellow Fever Vaccine Industry?

The yellow fever vaccine market research report is one of a series of new reports from The Business Research Company that provides yellow fever vaccine market statistics, including yellow fever vaccine industry global market size, regional shares, competitors with a yellow fever vaccine market share, detailed yellow fever vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the yellow fever vaccine industry. This yellow fever vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Yellow Fever Vaccine Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $4.79 billion
Revenue Forecast In 2034 $5.84 billion
Growth Rate CAGR of 5.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users Subsegments: 1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Yellow Fever Vaccine Market Characteristics

    3. Yellow Fever Vaccine Market Trends And Strategies

    4. Yellow Fever Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Yellow Fever Vaccine Growth Analysis And Strategic Analysis Framework

    5.1. Global Yellow Fever Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Yellow Fever Vaccine Market Growth Rate Analysis

    5.4. Global Yellow Fever Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Yellow Fever Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Yellow Fever Vaccine Total Addressable Market (TAM)

    6. Yellow Fever Vaccine Market Segmentation

    6.1. Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Powder

    Liquid

    6.2. Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pain Management Drugs

    Oral Rehydration

    6.3. Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Routine Immunization

    Travelers

    Other Applications

    6.4. Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Diagnostic Centers

    Point Of Care Centers

    Other End Users

    6.5. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lyophilized Powder For Reconstitution

    Freeze-Dried Powder For Reconstitution

    6.6. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ready-To-Use Liquid Vaccine

    Liquid Vaccine In Pre-Filled Syringes

    7. Yellow Fever Vaccine Market Regional And Country Analysis

    7.1. Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Yellow Fever Vaccine Market

    8.1. Asia-Pacific Yellow Fever Vaccine Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Yellow Fever Vaccine Market

    9.1. China Yellow Fever Vaccine Market Overview

    9.2. China Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Yellow Fever Vaccine Market

    10.1. India Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Yellow Fever Vaccine Market

    11.1. Japan Yellow Fever Vaccine Market Overview

    11.2. Japan Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Yellow Fever Vaccine Market

    12.1. Australia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Yellow Fever Vaccine Market

    13.1. Indonesia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Yellow Fever Vaccine Market

    14.1. South Korea Yellow Fever Vaccine Market Overview

    14.2. South Korea Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Yellow Fever Vaccine Market

    15.1. Western Europe Yellow Fever Vaccine Market Overview

    15.2. Western Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Yellow Fever Vaccine Market

    16.1. UK Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Yellow Fever Vaccine Market

    17.1. Germany Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Yellow Fever Vaccine Market

    18.1. France Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Yellow Fever Vaccine Market

    19.1. Italy Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Yellow Fever Vaccine Market

    20.1. Spain Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Yellow Fever Vaccine Market

    21.1. Eastern Europe Yellow Fever Vaccine Market Overview

    21.2. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Yellow Fever Vaccine Market

    22.1. Russia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Yellow Fever Vaccine Market

    23.1. North America Yellow Fever Vaccine Market Overview

    23.2. North America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Yellow Fever Vaccine Market

    24.1. USA Yellow Fever Vaccine Market Overview

    24.2. USA Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Yellow Fever Vaccine Market

    25.1. Canada Yellow Fever Vaccine Market Overview

    25.2. Canada Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Yellow Fever Vaccine Market

    26.1. South America Yellow Fever Vaccine Market Overview

    26.2. South America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Yellow Fever Vaccine Market

    27.1. Brazil Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Yellow Fever Vaccine Market

    28.1. Middle East Yellow Fever Vaccine Market Overview

    28.2. Middle East Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Yellow Fever Vaccine Market

    29.1. Africa Yellow Fever Vaccine Market Overview

    29.2. Africa Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Yellow Fever Vaccine Market Competitive Landscape And Company Profiles

    30.1. Yellow Fever Vaccine Market Competitive Landscape

    30.2. Yellow Fever Vaccine Market Company Profiles

    30.2.1. Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis

    31. Yellow Fever Vaccine Market Other Major And Innovative Companies

    31.1. WuXi Biologics

    31.2. Novavax Inc.

    31.3. Beijing Tiantan Biological

    31.4. Bavarian Nordic A/S

    31.5. Valneva SE

    31.6. Biological E. Limited

    31.7. Bio-Manguinhos

    31.8. Instituto Butantan

    31.9. Bio Farma

    31.10. Panacea Biotec

    31.11. Biovac

    31.12. Institut Pasteur de Dakar

    31.13. Ology Bioservices

    31.14. Gavi

    31.15. Wuhan Institute of Biological Products

    32. Global Yellow Fever Vaccine Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Yellow Fever Vaccine Market

    34. Recent Developments In The Yellow Fever Vaccine Market

    35. Yellow Fever Vaccine Market High Potential Countries, Segments and Strategies

    35.1 Yellow Fever Vaccine Market In 2029 - Countries Offering Most New Opportunities

    35.2 Yellow Fever Vaccine Market In 2029 - Segments Offering Most New Opportunities

    35.3 Yellow Fever Vaccine Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Merck and Co Inc. Financial Performance
  • Table 78: Sanofi S.A. Financial Performance
  • Table 79: GSK plc Financial Performance
  • Table 80: Takeda Pharmaceutical Company Financial Performance
  • Table 81: Lonza Group Ag Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Merck and Co Inc. Financial Performance
  • Figure 78: Sanofi S.A. Financial Performance
  • Figure 79: GSK plc Financial Performance
  • Figure 80: Takeda Pharmaceutical Company Financial Performance
  • Figure 81: Lonza Group Ag Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Yellow Fever Vaccine market?

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas. For further insights on the Yellow Fever Vaccine market, request a sample here

How will the Yellow Fever Vaccine market drivers and restraints affect the market dynamics? What forces will shape the Yellow Fever Vaccine industry going forward?

The Yellow Fever Vaccine market major growth driver - Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel. For further insights on the Yellow Fever Vaccine market, request a sample here

What is the forecast market size or the forecast market value of the Yellow Fever Vaccine market?

The Yellow Fever Vaccine market size has grown strongly in recent years. The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology. The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness. For further insights on the Yellow Fever Vaccine market, request a sample here

How is the Yellow Fever Vaccine market segmented?

The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes For further insights on the Yellow Fever Vaccine market,
request a sample here

Which region has the largest share of the Yellow Fever Vaccine market? What are the other regions covered in the report?

North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Yellow Fever Vaccine market, request a sample here.

Who are the major players in the Yellow Fever Vaccine market?

Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. A T-cell adaptive booster vaccine is a type of vaccine designed to enhance the immune system's memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.. For further insights on the Yellow Fever Vaccine market, request a sample here.

What are the key trends in the Yellow Fever Vaccine market?

Major trends in the Yellow Fever Vaccine market include Innovative T-Cell Adaptive Booster Vaccines Enhancing Global Yellow Fever Immunity. For further insights on the Yellow Fever Vaccine market, request a sample here.

What are the major opportunities in the Yellow Fever Vaccine market? What are the strategies for the Yellow Fever Vaccine market?

For detailed insights on the major opportunities and strategies in the Yellow Fever Vaccine market, request a sample here.

How does the Yellow Fever Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Yellow Fever Vaccine's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Yellow Fever Vaccine industry?

For detailed insights on the mergers and acquisitions in the Yellow Fever Vaccine industry, request a sample here.

What are the key dynamics influencing the Yellow Fever Vaccine market growth? SWOT analysis of the Yellow Fever Vaccine market.

For detailed insights on the key dynamics influencing the Yellow Fever Vaccine market growth and SWOT analysis of the Yellow Fever Vaccine industry, request a sample here.